27^th European Diabetes Congress June 20-21, 2018 | Rome, Italy

Mr. Douglas Ishii is currently employed at Aurogen Incorporated in the position of Founder, Board Member, and Chief Executive Officer. He was Assoc. Prof, Pharmacology at College of Physicians & Surgeons, Columbia Univ., New York City. He is Professor of Physiology as well as Professor of Biochemistry & Molecular Biology at Colorado State Univ., Colorado. Dr. Ishii has served on many scientific advisory panels for the National Institutes of Health, National Science Foundation, and Juvenile Diabetes Foundation International. He did his B.A. in biochemistry from University of Calif. Berkeley. Then he completed his Ph.D. in pharmacology from Stanford University Sch. Medicine, and a postdoctoral in neurobiology from Stanford University Sch. Medicine. He is recipient of research scientist of the Year by CSURF in 2001 and a National Research Career Development Award.

Douglas Ishii interested in the neurobiology of the neurotrophic insulin-like growth factor (IGF) hormones, as well as their capacity to treat various neurological diseases and disorders. This laboratory discovered that IGFs are circulating neurotrophic factors. The highest levels of IGF-II gene expression are in brain, spinal cord, and nerves, and its expression in perinatal muscle correlates closely with synaptogenesis in rats. Neurite (axon or dendrite) outgrowth and the survival of neurons in culture are supported by IGFs. Following nerve crush, infusion of IGFs increase, whereas anti-IGF antibodies decrease the rate of sciatic nerve regeneration in rats. IGF-I mRNAs are increased all along the nerve distal to crush, whereas IGF-II mRNAs are increased mostly at the end of nerves and in denervated muscle. Disconnection of nerves from muscle results in motoneuron death in neonatal rats. Such motoneuron death is prevented by IGF-II, whereas exacerbated by anti-IGF antibodies. Others have shown that transgenic mice over-expressing IGF-I have brains 55% larger than normal.

Dr. Arturo Solís Herrera, MD, PhD., has been Graduated from Institute Polytechnic Nacional, from CDMX, in 1978 as Medicine Doctor, with the specialties including Ophthalmology, in the National University of Mexico, and Neuro-Ophthalmology, at INNN, México. Later on he obtained his Master Science Degree from University of Aguascalientes, México, and thereafter a PhD in Pharmacology, Universidad de Guadalajara, México. Dr. Solís Herrera is director and founder of Human Photosynthesis® Research Center, in Ags., México, in 2007; where he has continued his research until today.

The discovery of a biochemical process, that from a molecule that exists on the skin, hair and coating the human retina but can be produced artificially, (melanin or polihidroxiindol), is capable of breaking the molecule water, separating the hydrogen and oxygen and extracting energy from this process. The raw material of this invention is abundant in nature, as its core components are water and a molecule that exists in the skin, hair and the lining of the human retina, but that can be produced artificially: melanin or polihidroxiindol.

Dr. L0pes-Virella is one of most famous doctor in the Charleston, Lopes-Virella is practicing in medical field for 48 Years. Doctor Maria completed its graduation from Other in the year 1967 and was awarded with degree by the medical institute OTHER. From 48 years Dr. Maria F Lopes-Virella had been awarded by local authorities in the state SC, USA.

Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes.

David E. Cummings, M.D. is a Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington, based at the Diabetes & Obesity Center of Excellence and the V.A. Puget Sound Health Care System. He studies the hormonal and neurochemical pathways that regulate appetite, body weight, and glucose homeostasis. A major current focus of his research is to elucidate endocrine mechanisms mediating the profound effects of bariatric/metabolic surgery on diabetes and body weight, as well as to determine the role of surgery in diabetes care through randomized clinical trials.

Dr. Cummings and his research have been widely featured in the media, including on 60 Minutes, Good Morning America, Time, Newsweek, the New York Times, Wall Street Journal, US News & World Report, NPR, the BBC, and many others. He has presented his work to the United States Congress, at universities throughout the world, and to the Nobel Committee in Medicine and Physiology on two separate occasions at Nobel Symposia in Stockholm.

Shaaban Abdallah, a professor of Aerospace Engineering, has been at the university of Cincinnati since 1989. He obtained his PhD in Aerospace Engineering at the university of Cincinnati in 1980. Dr. Abdallah joined Penn State University from 1981 to 1988. His research interests include Computational Fluid Dynamics, nano fluids, Turbo-machines, Unmanned Aerial Vehicles and Medical devices. Abdallah has two US patents on centrifugal compressors and three disclosures with university of Cincinnati on medical devices.

Energy loss And coronary flow simulation following hybrid stage l palliation: a hypoplastic left heart computational fluid dynamic model, Interactive cardiovascular and Thoracic Surgery.

Malcolm Carruthers is a Founder and Chief Medical Consultant to the Centre for Men's Health, He has spent 30 years on research into testosterone treatment. He is Adjunct Professor at the Alzheimer's and Aging Department, Edith Cowan University, Western Australia as well as being a Fellow of the Royal College of Pathologist. He is a life member of the Royal College of General Practitioners (RCGP). He is also President of the Society for the Study of Androgen Deficiency (Andropause Society), a member of the British Cardiovascular Society, the European Academy of Andrology, the International and European Societies for the Study of the Aging Male and a past President of the Society for Psychosomatic Research.

Malcolm Carruthers is interested in Testosterone Replacement Therapy (TRT) in 1977 when he saw the remarkable results being obtained by the pioneer of the treatment, Dr Jen Moller, in Copenhagen. In 1988 Dr Carruthers set up what is now the Centre For Men's Health in Harley Street, specialising in the diagnosis and treatment of testosterone deficiency- the male menopause- or andropause. He subsequently became a member of the European Academy of Andrology and International and European Societies for the Study of the Aging Male.

David Klachko is a Professor Emeritus in department of Endocrinology, Metabolism and DiabetesIn University of Missouri Health, Columbia

David Klachko research interest in diabetes, metabolism and endocrine disorders.

Julian Hamilton-Shield is a Professor in department of Diabetes and Metabolic Endocrinology In University of Bristol, UK

His main research interests encompass neonatal glucose metabolism, childhood obesity and its treatment, diabetes mellitus and the development of insulin resistance through childhood.

Irina Kurnikova has become Doctor of Medical Sciences (PhD) in 2010, the first academic degree (MD) received at the age of 28 years. Dealing with Problems of Endocrinology more than 20 years. Irina Kurnikova had led a course of endocrinology at the Medical Academy (Izhevsk, Russia), endocrinology department at the Russian Scientific Center of Medical Rehabilitation and Health Resort (Moscow, Russia). Currently she teaches at Peoples' Friendship University of Russia, curator of the scientific direction of endocrinology. Irina Kurnikova has published more than 20 articles in well-known journals, the author of 25 books and manuals in Russian, 9 patents for inventions.

Irina Kurnikova research interest in regulatory system in diabetes type 2

Emeritus ad hominem Professor of Medicine; Honorary Lecturer at University of Cardiff School of Medicine

Managing and guiding care of people with type 1 and type 2 diabetes, prevention of acute & chronic complications, and managing existent chronic/acute complications; Affiliated to the Centres of Diabetes Excellence (CDE). Honorary Tutor at the Cardiff School of Medicine, Wales, UK Deliver talks on Diabetes Care and Updates to Postgraduates. Provide advice to numerous pharmaceutical Advisory Boards

Alain, MBBS, MSc, MMSc, MPhil, MMed, PhD is a physician and academic researcher at the University of South Wales, Associate of Texila American University and Director of UCIC and Maris Stella Diabetes Academy in DRC. He is graduated from African, UK and American prestigious universities (such as UCT, Liverpool, Glamorgan, UCN and South wales), trained from old and sophisticated setting with a medical experience of more than 20 years in advanced medical fields; including: internal medicine, Diabetology, Paediatric and Clinical Research. He is also a member of ISPAD (international society of paediatric and adolescent diabetes) and Danish Diabetes Academy.

Nebulised insulin, food consumption patterns and nutritional status of diabetics in Sub-Saharan rural areas, reducing the risk of death on arrival and hospital stay of diabetics acutely in emergency setting by using evidence scales, suicidal risk behavior in young diabetics

Rui Santos Cruz is PhD in Health Sciences - Faculty of Medicine. University of Coimbra; MSc in Health Sociopsychology; Bachelor Degree in Pharmacy and Postgraduate in Law of Pharmacy and Medicine. He is coordinator professor in Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Department of Pharmacy, Portugal.

Drug Utilization Studies; Therapeutics for Diabetes type 2; Therapeutic Adherence and its Determinants.